Mersana Therapeutics Ownership | Who Owns Mersana Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Mersana Therapeutics Ownership Summary


Mersana Therapeutics is owned by 94.80% institutional investors, 1.26% insiders, and 3.94% retail investors. Ecor1 capital is the largest institutional shareholder, holding 15.95% of MRSN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.82% of its assets in Mersana Therapeutics shares.

MRSN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMersana Therapeutics94.80%1.26%3.94%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ecor1 capital19.36M15.95%$38.92M
Vr adviser11.33M9.33%$22.77M
Nextech invest9.53M7.85%$19.15M
Bain capital life sciences investors8.66M7.13%$17.41M
Blackrock8.38M6.90%$16.85M
Vanguard group6.70M5.52%$13.47M
Rock springs capital management lp3.05M2.51%$6.12M
Schonfeld strategic advisors2.98M2.45%$5.98M
State street2.68M2.21%$5.39M
Silverarc capital management2.50M2.06%$5.03M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nextech invest9.53M3.22%$19.15M
Acuta capital partners1.66M2.82%$3.34M
Bain capital life sciences investors8.66M1.91%$17.41M
Vr adviser11.33M1.45%$22.77M
Ecor1 capital19.36M1.19%$38.92M
Silverarc capital management2.50M1.19%$5.03M
5am venture management1.30M0.59%$2.62M
Octagon capital advisors lp992.00K0.31%$1.99M
Healthinvest partners ab184.90K0.23%$371.65K
Rock springs capital management lp3.05M0.18%$6.12M

Top Buyers

HolderShares% AssetsChange
Nextech invest9.53M3.22%5.67M
Schonfeld strategic advisors2.98M0.04%1.97M
Goldman sachs group1.24M0.00%572.33K
Two sigma advisers, lp719.30K0.00%563.50K
Jpmorgan chase1.98M0.00%549.56K

Top Sellers

HolderShares% AssetsChange
Balyasny asset management---3.66M
State street2.68M0.00%-2.82M
Cormorant asset management, lp---2.60M
Woodline partners lp1.47M0.03%-1.47M
Millennium management691.78K0.00%-815.79K

New Positions

HolderShares% AssetsChangeValue
Corebridge financial61.03K0.00%61.03K$122.67K
Mirae asset global etfs56.95K0.00%56.95K$114.46K
Algert global44.66K0.00%44.66K$90.00K
Wolverine trading11.30K-11.30K$22.71K
Caption management10.20K0.00%10.20K$20.50K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-22.00
Optiver b.v.-1.59K
Pacer advisors-1.72K
Metropolitan life insurance co/ny-4.68K
State of wyoming-9.16K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2024121-3.20%116,077,3431.64%941.07%52-17.46%32-11.11%
Jun 30, 2024125-2.34%114,205,327-2.80%940.99%63-12.50%36-
Mar 31, 202412817.43%117,492,7653.79%971.10%7241.18%362.86%
Dec 31, 2023109-18.05%113,199,475-0.47%930.97%51-16.39%35-20.45%
Sep 30, 2023133-24.00%113,738,5841.10%980.90%61-37.11%444.76%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv3.47M2.82%-
iShares Russell 2000 ETF2.97M2.42%-6.66K
Vanguard Institutional Extnd Mkt Idx Tr1.52M1.24%-
Fidelity Small Cap Index1.18M0.96%-18.61K
State St Russell Sm/Mid Cp® Indx NL Cl C848.77K0.69%-23.30K
Vanguard Explorer Inv614.97K0.50%-
Fidelity Extended Market Index552.27K0.45%-45.46K
HealthInvest Sustainable Healthcare E538.62K0.44%-
iShares Russell 2000 Growth ETF527.13K0.43%-
iShares Russell 2000 Value ETF520.18K0.42%-

Recent Insider Transactions


DateNameRoleActivityValue
Oct 28, 2024Bala Mohan SVP, Chief Development OfficerSell$3.58K
Oct 02, 2024DeSchuytner Brian SVP, COO & CFOSell$16.18K
Oct 03, 2024DeSchuytner Brian SVP, COO & CFOSell$10.97K
Oct 03, 2024Carvajal Alejandra SVP, Chief Legal OfficerSell$10.97K
Oct 02, 2024Carvajal Alejandra SVP, Chief Legal OfficerSell$16.18K

Insider Transactions Trends


DateBuySell
2024 Q4-11
2024 Q3-1
2024 Q2--
2024 Q1-7
2023 Q4-1

MRSN Ownership FAQ


Who Owns Mersana Therapeutics?

Mersana Therapeutics shareholders are primarily institutional investors at 94.80%, followed by 1.26% insiders and 3.94% retail investors. The average institutional ownership in Mersana Therapeutics's industry, Biotech Stocks , is 47.04%, which Mersana Therapeutics exceeds.

Who owns the most shares of Mersana Therapeutics?

Mersana Therapeutics’s largest shareholders are Ecor1 capital (19.36M shares, 15.95%), Vr adviser (11.33M shares, 9.33%), and Nextech invest (9.53M shares, 7.85%). Together, they hold 33.12% of Mersana Therapeutics’s total shares outstanding.

Does Blackrock own Mersana Therapeutics?

Yes, BlackRock owns 6.90% of Mersana Therapeutics, totaling 8.38M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 16.85M$. In the last quarter, BlackRock increased its holdings by 288.18K shares, a 3.56% change.

Who is Mersana Therapeutics’s biggest shareholder by percentage of total assets invested?

Nextech invest is Mersana Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.22% of its assets in 9.53M Mersana Therapeutics shares, valued at 19.15M$.

Who is the top mutual fund holder of Mersana Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Mersana Therapeutics shares, with 2.82% of its total shares outstanding invested in 3.47M Mersana Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools